Afficher la couverture 'A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death | Delaunay, Tiphaine' en grand format
/5

0 avis

A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death

Archive ouverte

Delaunay, Tiphaine | Achard, Carole | Gregoire, Marc | Tangy, Frédéric | Boisgerault, Nicolas | Fonteneau, Jean-François

Edité par CCSD ; Humana Press/Springer Imprint -

International audience. Oncolytic immunotherapy efficacy relies partially on the induction of immunogenic tumor cell death following infection with oncolytic viruses (OV) to induce an antitumor immune response. Here, we describe a method to determine if an OV is able to induce such an immunogenic tumor cell death. This method consists in testing whether tumor cells lysed by an OV are able to induce the maturation of human monocyte-derived immature dendritic cells (Mo-iDC).

Consulter en ligne

Suggestions

Du même auteur

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus

Archive ouverte | Delaunay, Tiphaine | CCSD

International audience

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus. Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus: Interferon genes loss sensitizes tumor cells to viral lysis

Archive ouverte | Delaunay, Tiphaine | CCSD

International audience. Oncolytic immunotherapy is based on the use of non-pathogenic replicative oncolytic viruses (OV) that infect and kill exclusively tumor cells. Recently, we showed that the spontaneous oncolyt...

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response

Archive ouverte | Achard, Carole | CCSD

International audience. Attenuated measles virus (MV) is currently being evaluated as an oncolytic virus in clinical trials and could represent a new therapeutic approach for malignant pleural mesothelioma (MPM). He...

Chargement des enrichissements...